Advertisement
Screener

ADAPTIMMUNE THERAPEUTICS PLC (ADAPY) Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount

ADAPTIMMUNE THERAPEUTICS PLC Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount

ADAPTIMMUNE THERAPEUTICS PLC (ADAPY) reported Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount of $21.48 million for the 12-month period ending 2021-12-31, per its 10-K filed 2023-03-06.

Discontinued › Expense Statement › Income Tax

us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance · last filed 2023-03-06

  • ADAPTIMMUNE THERAPEUTICS PLC effective income tax rate reconciliation, change in deferred tax assets valuation allowance, amount for fiscal 2021 was $21.48M.
Period endEffective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount 12 month
2021-12-31$21.48M
10-K · filed 2023-03-06